|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao H and Zhang Z: Standardized diagnosis
and treatment of colorectal liver metastasis. Zhonghua Wei Chang
Wai Ke Za Zhi. 20:753–757. 2017.(In Chinese). PubMed/NCBI
|
|
3
|
Aust G, Zhu D, Van Meir EG and Xu L:
Adhesion GPCRs in tumorigenesis. Handb Exp Pharmacol. 234:369–396.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Drews J: Drug discovery: A historical
perspective. Science. 287:1960–1964. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zendman AJ, Cornelissen IM, Weidle UH,
Ruiter DJ and van Muijen GN: TM7XN1, a novel human EGF-TM7-like
cDNA, detected with mRNA differential display using human melanoma
cell lines with different metastatic potential. FEBS Lett.
446:292–298. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kausar T, Sharma R, Hasan MR, Tripathi SC,
Saraya A, Chattopadhyay TK, Gupta SD and Ralhan R: Clinical
significance of GPR56, transglutaminase 2, and NF-κB in esophageal
squamous cell carcinoma. Cancer Invest. 29:42–48. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shashidhar S, Lorente G, Nagavarapu U,
Nelson A, Kuo J, Cummins J, Nikolich K, Urfer R and Foehr ED: GPR56
is a GPCR that is overexpressed in gliomas and functions in tumor
cell adhesion. Oncogene. 24:1673–1682. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mori A, Arii S, Furutani M, Hanaki K,
Takeda Y, Moriga T, Kondo Y, Rivas Gorrin MJ and Imamura M:
Vascular endothelial growth factor-induced tumor angiogenesis and
tumorigenicity in relation to metastasis in a HT1080 human
fibrosarcoma cell model. Int J Cancer. 80:738–743. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Saito Y, Kaneda K, Suekane A, Ichihara E,
Nakahata S, Yamakawa N, Nagai K, Mizuno N, Kogawa K, Miura I, et
al: Maintenance of the hematopoietic stem cell pool in bone marrow
niches by EVI1-regulated GPR56. Leukemia. 27:1637–1649. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chiang NY, Peng YM, Juang HH, Chen TC, Pan
HL, Chang GW and Lin HH: GPR56/ADGRG1 activation promotes melanoma
cell migration via NTF Dissociation and CTF-mediated
galpha12/13/RhoA signaling. J Invest Dermatol. 137:727–736. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang L, Chen G, Mohanty S, Scott G, Fazal
F, Rahman A, Begum S, Hynes RO and Xu L: GPR56 Regulates VEGF
production and angiogenesis during melanoma progression. Cancer
Res. 71:5558–5568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo R, Jin Z, Deng Y, Strokes N and Piao
X: Disease-associated mutations prevent GPR56-collagen III
interaction. PLoS One. 7:e298182012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Little KD, Hemler ME and Stipp CS: Dynamic
regulation of a GPCR-tetraspanin-G protein complex on intact cells:
Central role of CD81 in facilitating GPR56-Galpha q/11 association.
Mol Biol Cell. 15:2375–2387. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Friedland S, Corson N and Xu L:
GPR56 inhibits melanoma growth by internalizing and degrading its
ligand TG2. Cancer Res. 74:1022–1031. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin G, Sakitani K, Wang H, Jin Y,
Dubeykovskiy A, Worthley DL, Tailor Y and Wang TC: The G-protein
coupled receptor 56, expressed in colonic stem and cancer cells,
binds progastrin to promote proliferation and carcinogenesis.
Oncotarget. 8:40606–40619. 2017.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Zhang C, Zhang Z, Qian W and Sun
Y, Ji B, Zhang Y, Zhu C, Ji D, Wang Q and Sun Y: Transcriptome
analysis in primary colorectal cancer tissues from patients with
and without liver metastases using next-generation sequencing.
Cancer Med. 6:1976–1987. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Y, Ji B, Feng Y, Ji D, Zhu C, Wang S,
Zhang C, Zhang D and Sun Y: TRIM59 facilitates the proliferation of
colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
Oncol Rep. 38:43–52. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kishore A and Hall RA: Disease-associated
extracellular loop mutations in the adhesion G protein-coupled
receptor G1 (ADGRG1; GPR56) differentially regulate downstream
signaling. J Biol Chem. 292:9711–9720. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tseng WY, Wu Jan YJ, Yang TY, Chiang NY,
Tsai WP, Gordon S, Chang GW, Kuo CF, Luo SF and Lin HH: High levels
of soluble GPR56/ADGRG1 are associated with positive rheumatoid
factor and elevated tumor necrosis factor in patients with
rheumatoid arthritis. J Microbiol Immunol Infect pii: S1684-1182.
30094. 2017.
|
|
21
|
Mehta P and Piao X: Adhesion G-protein
coupled receptors and extracellular matrix proteins: Roles in
myelination and glial cell development. Dev Dyn. 246:275–284. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ke N, Sundaram R, Liu G, Chionis J, Fan W,
Rogers C, Awad T, Grifman M, Yu D, Wong-Staal F and Li QX: Orphan G
protein-coupled receptor GPR56 plays a role in cell transformation
and tumorigenesis involving the cell adhesion pathway. Mol Cancer
Ther. 6:1840–1850. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Z, Huang Z, Yang W, Li Z, Xing S, Li
H, Hu B and Li P: Expression of orphan GPR56 correlates with tumor
progression in human epithelial ovarian cancer. Neoplasma.
64:32–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang L, Wang X and Lai M: Modulation of
epithelial-to-mesenchymal cancerous transition by natural products.
Fitoterapia. 106:247–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu PL, Liu WL, Chang JM, Chen YH, Liu YP,
Kuo HF, Hsieh CC, Ding YS, Chen WW and Chong IW: MicroRNA-200c
inhibits epithelial-mesenchymal transition, invasion, and migration
of lung cancer by targeting HMGB1. PLoS One. 12:e01808442017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang SC, Chai DS, Chen CB, Wang ZY and
Wang L: HPIP promotes thyroid cancer cell growth, migration and EMT
through activating PI3K/AKT signaling pathway. Biomed Pharmacother.
75:33–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei S, Wang L, Zhang L, Li B, Li Z, Zhang
Q, Wang J, Chen L, Sun G, Li Q, et al: ZNF143 enhances metastasis
of gastric cancer by promoting the process of EMT through PI3K/AKT
signaling pathway. Tumour Biol. 37:12813–12821. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song Y, Li ZX, Liu X, Wang R, Li LW and
Zhang Q: The Wnt/β-catenin and PI3K/Akt signaling pathways promote
EMT in gastric cancer by epigenetic regulation via H3 lysine 27
acetylation. Tumour Biol. 39:10104283177126172017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu H, He Y, Qi L, Chen L, Luo Y, Chen L,
Li Y, Zhang N and Guo H: cPLA2α activates PI3K/AKT and inhibits
Smad2/3 during epithelial-mesenchymal transition of hepatocellular
carcinoma cells. Cancer Lett. 403:260–270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu Q, Liu X, Liu Z, Wang Y, Tu J, Li L,
Bao H, Yang L and Tu K: MicroRNA-1296 inhibits metastasis and
epithelial-mesenchymal transition of hepatocellular carcinoma by
targeting SRPK1-mediated PI3K/AKT pathway. Mol Cancer. 16:1032017.
View Article : Google Scholar : PubMed/NCBI
|
